269 related articles for article (PubMed ID: 19064201)
21. Conventional MRI in multiple sclerosis.
Filippi M; Rocca MA
J Neuroimaging; 2007 Apr; 17 Suppl 1():3S-9S. PubMed ID: 17425727
[TBL] [Abstract][Full Text] [Related]
22. Magnetic resonance techniques to quantify tissue damage, tissue repair, and functional cortical reorganization in multiple sclerosis.
Filippi M; Agosta F
Prog Brain Res; 2009; 175():465-82. PubMed ID: 19660674
[TBL] [Abstract][Full Text] [Related]
23. [Multiple sclerosis and magnetic resonance].
Jinochová M; Seidl Z; Obenberger J; Krásenský J; Havrdová E; Viták T; Peterová V; Danes J
Cas Lek Cesk; 2003 Mar; 142(3):144-9. PubMed ID: 12756841
[TBL] [Abstract][Full Text] [Related]
24. Optical coherence tomography in the diagnosis and management of optic neuritis and multiple sclerosis.
Costello FE; Klistorner A; Kardon R
Ophthalmic Surg Lasers Imaging; 2011 Jul; 42 Suppl():S28-40. PubMed ID: 21790109
[TBL] [Abstract][Full Text] [Related]
25. Multiple sclerosis and the ophthalmologist.
Mowry EM; Balcer LJ; Galetta SL
Compr Ophthalmol Update; 2007; 8(1):39-49. PubMed ID: 17394758
[TBL] [Abstract][Full Text] [Related]
26. Advances in multiple sclerosis and its variants: conventional and newer imaging techniques.
Miller TR; Mohan S; Choudhri AF; Gandhi D; Jindal G
Radiol Clin North Am; 2014 Mar; 52(2):321-36. PubMed ID: 24582342
[TBL] [Abstract][Full Text] [Related]
27. Optical coherence tomography in multiple sclerosis.
Frohman E; Costello F; Zivadinov R; Stuve O; Conger A; Winslow H; Trip A; Frohman T; Balcer L
Lancet Neurol; 2006 Oct; 5(10):853-63. PubMed ID: 16987732
[TBL] [Abstract][Full Text] [Related]
28. Non-conventional MR techniques in monitoring MS activity and evolution.
Filippi M
Electroencephalogr Clin Neurophysiol Suppl; 1999; 50():565-9. PubMed ID: 10689510
[No Abstract] [Full Text] [Related]
29. [MRI and MRS diagnosis. Application in multiple sclerosis patients and research animals with experimental allergic encephalomyelitis].
's-Gravenmade EJ; Minderhoud JM
Ned Tijdschr Tandheelkd; 1993 Apr; 100(4):195-200. PubMed ID: 11908453
[TBL] [Abstract][Full Text] [Related]
30. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients.
Lebrun C; Bensa C; Debouverie M; Wiertlevski S; Brassat D; de Seze J; Rumbach L; Pelletier J; Labauge P; Brochet B; Tourbah A; Clavelou P;
Arch Neurol; 2009 Jul; 66(7):841-6. PubMed ID: 19597085
[TBL] [Abstract][Full Text] [Related]
31. [Cerebral and spinal MRI examination in patients with clinically isolated syndrome and definite multiple sclerosis].
Sailer M; Fazekas F; Gass A; Kappos L; Radue EW; Rieckmann P; Toyka K; Wiendl H; Bendszus M
Rofo; 2008 Nov; 180(11):994-1001. PubMed ID: 18937154
[TBL] [Abstract][Full Text] [Related]
32. Evidence for gray matter pathology in multiple sclerosis: a neuroimaging approach.
Zivadinov R; Minagar A
J Neurol Sci; 2009 Jul; 282(1-2):1-4. PubMed ID: 19345379
[TBL] [Abstract][Full Text] [Related]
33. Toward a practical protocol for human optic nerve DTI with EPI geometric distortion correction.
Techavipoo U; Okai AF; Lackey J; Shi J; Dresner MA; Leist TP; Lai S
J Magn Reson Imaging; 2009 Oct; 30(4):699-707. PubMed ID: 19787713
[TBL] [Abstract][Full Text] [Related]
34. Functional MR imaging in multiple sclerosis.
Filippi M; Rocca MA
Neuroimaging Clin N Am; 2009 Feb; 19(1):59-70. PubMed ID: 19064200
[TBL] [Abstract][Full Text] [Related]
35. Advanced magnetic resonance imaging metrics: implications for multiple sclerosis clinical trials.
Zivadinov R
Methods Find Exp Clin Pharmacol; 2009; 31(1):29-40. PubMed ID: 19357796
[TBL] [Abstract][Full Text] [Related]
36. Gadofluorine M enhancement allows more sensitive detection of inflammatory CNS lesions than T2-w imaging: a quantitative MRI study.
Bendszus M; Ladewig G; Jestaedt L; Misselwitz B; Solymosi L; Toyka K; Stoll G
Brain; 2008 Sep; 131(Pt 9):2341-52. PubMed ID: 18669504
[TBL] [Abstract][Full Text] [Related]
37. Magnetic resonance imaging metrics and their correlation with clinical outcomes in multiple sclerosis: a review of the literature and future perspectives.
Bar-Zohar D; Agosta F; Goldstaub D; Filippi M
Mult Scler; 2008 Jul; 14(6):719-27. PubMed ID: 18424478
[TBL] [Abstract][Full Text] [Related]
38. Magnetization transfer imaging.
van Buchem MA; Tofts PS
Neuroimaging Clin N Am; 2000 Nov; 10(4):771-88 ,ix. PubMed ID: 11359724
[TBL] [Abstract][Full Text] [Related]
39. The contribution of magnetic resonance imaging to the assessment of optic nerve and spinal cord involvement in multiple sclerosis.
Moseley IF; Miller DH; Gass A
J Neurol Neurosurg Psychiatry; 1998 May; 64 Suppl 1():S15-20. PubMed ID: 9647279
[TBL] [Abstract][Full Text] [Related]
40. Optical Coherence Tomography to Assess Neurodegeneration in Multiple Sclerosis.
Petzold A
Methods Mol Biol; 2016; 1304():131-41. PubMed ID: 25476442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
